Transcat, Inc. (NASDAQ:TRNS – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the five analysts that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $105.3333.
A number of analysts recently weighed in on TRNS shares. Zacks Research raised Transcat from a “strong sell” rating to a “hold” rating in a report on Wednesday, March 4th. Weiss Ratings reissued a “sell (d+)” rating on shares of Transcat in a report on Monday, December 29th.
View Our Latest Stock Report on TRNS
Transcat Price Performance
Transcat (NASDAQ:TRNS – Get Free Report) last released its earnings results on Tuesday, February 3rd. The scientific and technical instruments company reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by ($0.04). The business had revenue of $83.86 million for the quarter, compared to analyst estimates of $80.99 million. Transcat had a return on equity of 6.15% and a net margin of 2.47%. Research analysts anticipate that Transcat will post 2.3 earnings per share for the current year.
Institutional Trading of Transcat
Several hedge funds and other institutional investors have recently made changes to their positions in TRNS. White Pine Capital LLC boosted its holdings in Transcat by 1.7% during the second quarter. White Pine Capital LLC now owns 10,175 shares of the scientific and technical instruments company’s stock worth $875,000 after buying an additional 171 shares in the last quarter. Police & Firemen s Retirement System of New Jersey increased its holdings in Transcat by 14.8% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 2,238 shares of the scientific and technical instruments company’s stock valued at $192,000 after buying an additional 288 shares in the last quarter. Deutsche Bank AG lifted its position in shares of Transcat by 4.6% during the 4th quarter. Deutsche Bank AG now owns 7,053 shares of the scientific and technical instruments company’s stock valued at $400,000 after acquiring an additional 312 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Transcat by 6.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company’s stock valued at $407,000 after acquiring an additional 325 shares during the period. Finally, Swiss National Bank boosted its stake in shares of Transcat by 2.2% during the 4th quarter. Swiss National Bank now owns 18,315 shares of the scientific and technical instruments company’s stock worth $1,039,000 after acquiring an additional 400 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.
About Transcat
Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.
In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.
Featured Stories
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.
